Estradiol/Norethindrone Acetate (CombiPatch)

About

CombiPatch is a combination hormone therapy patch containing estradiol and norethindrone acetate (a progestin). FDA-approved for treatment of moderate to severe vasomotor symptoms associated with menopause and for the prevention of postmenopausal osteoporosis in women with an intact uterus.

Efficacy

Clinical trials show significant reduction in frequency and severity of vasomotor symptoms compared to placebo

Targets Symptoms